Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alpha Amino Tertiary Borate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106146543A details efficient Rh-catalyzed synthesis of chiral alpha-amino tertiary borates, offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.